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Mutations in the gene encoding valosin-containing protein
(VCP) lead to multisystem proteinopathies including fronto-
temporal dementia. We have previously shown that patient-
derived VCP mutant fibroblasts exhibit lower mitochondrial
membrane potential, uncoupled respiration, and reduced ATP
levels. This study addresses the underlying basis for mitochon-
drial uncoupling using VCP knockdown neuroblastoma cell
lines, induced pluripotent stem cells (iPSCs), and iPSC-derived
cortical neurons from patients with pathogenic mutations in
VCP. Using fluorescent live cell imaging and respiration analysis
we demonstrate a VCPmutation/knockdown-induced dysregu-
lation in the adenine nucleotide translocase, which results in a
slower rate of ADP or ATP translocation across the mitochon-
drial membranes. This deregulation can explain the mitochon-
drial uncoupling and lowerATP levels inVCPmutation-bearing
neurons via reduced ADP availability for ATP synthesis. This
study provides evidence for a role of adenine nucleotide trans-
locase in the mechanism underlying altered mitochondrial
function in VCP-related degeneration, and this new insightmay
inform efforts to better understand and manage neurodegen-
erative disease and other proteinopathies.
Valosin-containing protein (VCP)3 (alias p97/TERA) is a
ubiquitously expressed member of the type II AAA ATPase
family. Mutations in VCP have been found in patients with
inclusion body myopathy with early-onset Paget disease and
frontotemporal dementia aswell as familial amyotrophic lateral
sclerosis (ALS). VCP has been linked to a variety of cellular
functions including ubiquitin-proteasome system, protein deg-
radation at the outer mitochondrial membrane, and autophagy
but the underlying molecular mechanism in disease is yet to be
fully understood.
Clues to the molecular mechanism associated with VCP
mutations have come from model organisms that possess high
inter-species homologies in the VCP protein. In particular,
mutant mouse knock-in models mirror age-depandant motor-
neuron dysfunction (1, 2). Abnormalities have been found
in mitochondria cristae structures suggesting mitochondrial
pathology in VCP mutation bearing cells (3). Our recent work
has provided an insight into the observed mitochondrial
pathologies through the utilization of a human dopaminergic
neuroblastoma VCP knockdown cell line (SH-SY5Y), fibro-
blasts from patients carrying pathogenic mutations in the VCP
gene and VCP knockdown mouse neurons, where we revealed
an uncoupling of respiration from oxidative phosphorylation.
Furthermore, it was shown that uncoupling leads to a lower
mitochondrial membrane potential (indicator of cell health),
higher respiration, and lower ATP levels in these cells (4). We
hypothesized that the VCP mutation-induced uncoupling
event may occur due to one of two reasons: 1) uncoupling pro-
teins (UCPs) may alter themitochondrial proton gradient, thus
uncoupling respiration from oxidative phosphorylation. 2)
Dysfunctional adenine nucleotide translocase (ANT1, SLC25A4),
which is responsible for the simultaneous ADP import and ATP
export across the mitochondrial inner membrane, leading to
reduced ADP substrate for oxidative phosphorylation.
Other studies have investigated the effects of VCP on cellular
health in patient fibroblasts, SH-SY5Y, as well as myoblasts (5)
and this present study is the first to employ a disease-relevant
neuronal model. In this current study, we set out to generate a
human neuronalmodel ofVCPmutations to explain the under-
lying mechanism of mitochondrial uncoupling in VCPmutant
cells. To produce a human neuronal cell model, expressing
mutant VCP at physiological levels, we generated iPSCs from
patient fibroblasts and subsequently differentiated the cells
to cortical neurons to study mitochondrial function. Live cell
imaging techniques and a combination of VCP knockdown
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SH-SY5Y cell lines as well as iPSCs and iPSC-derived neurons
enabled us to establish that a reduced activity of ANT1 leads to
the uncoupling of mitochondria inVCPmutation bearing cells.
Results
Uncoupling of VCPmutation bearing cells is not caused by
UCPs
Our previous study provided evidence of lower ATP levels as
well as uncoupledmitochondria (4). To investigate this further,
we assessed mitochondrial coupling in stable VCP knockdown
(KD) and scrambled (SCR) SH-SY5Y neuroblastoma cell lines.
The VCP KD mimics the dominant-negative effect displayed
by pathogenic loss-of-function VCP mutations. As previously
shown by Bartolome et al. (4), VCP KD cells (clones KD#1,
KD#2 and KD#3) displayed a significantly lower respiratory
control rate (RCR; an indicator of coupling of oxidative phos-
phorylation and respiration) when compared with SCR cells
(Fig. 1 A; n 3 experiments; p 0.01). To assess whether the
mitochondrial uncoupling in SH-SY5Y VCP KD cells is caused
by UCPs, permeabilized cells were pre-exposed for 1min to the
UCP inhibitors GDP (100M) or Genipin (50M) and the cou-
pling of oxidative phosphorylation and respirationwas assessed
(Fig. 1A). Application of GDP and Genipin did not alter the
RCR of SCR or VCP KD cells indicating that UCPs are not the
underlying reason for the mitochondrial uncoupling in VCP
mutants (n 3 experiments). In support of this finding, West-
ern blotting for UCP2 showed equal levels in control and VCP
KD cells (Fig. 1B). Protein levels of mitochondrial electron
transport chain (ETC) complexes were also found to be
unchanged in VCP KD cells when compared with control sug-
gesting that the mitochondrial phenotype is not caused by an
alteration in ETC complex expression (Fig. 1D).
Lack of ATP synthase substrate in VCP KD cells
Due to the difference in charge between ATP and ADP,
changes in ANT activity can affect mitochondrial membrane
potential and respiration. To test whether this is the underlying
cause of the uncoupling event observed in VCP knockdown
cells, we exposed SCR control andVCPKD cells to ANT inhib-
itors carboxyatractyloside (CATR; 5 M) or bongkrekic acid
(BKA) (5 M) and RCR was assessed. Inhibition of ANT
resulted in a significantly reduced RCR in SCR cells, whichmir-
rors the RCR observed in SH-SY5Y VCP KD cells (Fig. 1A; p
0.01; n  3 experiments). Furthermore, the lower RCR in the
ANT inhibitor-treated SCRcell suggests that inhibition ofANT
alone is able to uncouple mitochondria. There was no addi-
tional reduction inRCR inVCPKDcells exposed toANT inhib-
itors suggesting that ANT is already inhibited and substrate
(ADP) supply is reduced (Fig. 1A). To exclude a reduced ANT1
expression being the underlying reason, aWestern blot analysis
probing for ANT1 was undertaken. No changes in total ANT1
protein expression were found in VCP KD cells (Fig. 1B).
A proton leak through the ATP synthase could be the under-
lying reason for uncoupled mitochondria in VCP KD cells (6).
Therefore, the irreversible ATP synthase inhibitor oligomycin
(2 g/ml) was applied (Fig. 1C). Oligomycin induced much
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Figure 1. A, RCR is the ratio of state 3 respiration (ADP stimulated) to state 4 respiration (no ADP present), and is considered an indication of the degree of
coupling of mitochondrial respiratory chain activity to oxidative phosphorylation. RCR of mitochondria in permeabilized SHY5Y control and VCP knockdown
cells (KD#1, KD#2, KD#3) in the presence of vehicle control, uncoupling protein inhibitors (GDP; Genipin), or ANT inhibitors (CATR; BKA). B, SHY5Y SCR and KD
cellswereprobed forVCP,ANT1,UCP2, and-actinbyWesternblotting (cropped).C,quantificationofVBasal/Voligomycin inpermeabilizedSHY5Ycontrol andVCP
knockdown cells as an alternative indicator of coupling of mitochondrial respiratory chain activity to oxidative phosphorylation. D, full-length representative
Western blot analysis of whole cell lysates from stable SCR SH-SY5Y cells and stable VCP knockdown SH-SY5Y cells probing for mitochondrial complexes and
-actin. *, p 0.05; **, p 0.01; ***, p 0.001.
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smaller inhibition of respiration inVCPKD cells providing evi-
dence that the uncoupling of these mitochondria is not caused
by a proton leak in these cells. These results suggest that sub-
strate supply in the form of ADP is limited in VCP KD cells
leading to mitochondrial uncoupling.
Generation of VCPmutant iPSCs and cortical neurons
To further our understanding of mutant-VCP disease mech-
anism, we employed a more physiologically relevant model in
the form of patient-derived iPSCs and iPSC-derived neurons.
Fibroblasts from two patients carrying the R155C (most
prevalent VCP mutation) and R191Q mutations were repro-
grammed to iPSCs using episomal reprogramming factors (7).
These patients both exhibited autosomal dominant inclusion
body myopathy and frontotemporal dementia (FTD). The
resultant iPSC clones exhibited similar expression of pluripo-
tency markers to control hESCs at the protein (Fig. 2A) and
RNA level (Fig. 2B). Reprogrammed cells exhibited a stable
karyotypewith unaltered g-banding (data not shown) andDNA
sequencing confirmed that these stem cell lines retained the
VCP mutation (Fig. 2D). The potential of the cells to differen-
tiate into three germ layers was confirmed (Fig. 2E). Two clones
from each patient were taken forward for further experiments
and compared with two control iPSC lines and one control
hESC line.
iPSCs were differentiated into cortical neurons, which are
affected in VCP-linked FTD, as described previously (8). After
80 days of neurogenesis, control and VCP mutant lines gener-
ated similar proportions of deep (TBR1), middle (CTIP2), and
upper (SATB2) cortical neurons (Fig. 2, A, ii, and F). The faith-
ful silencing of pluripotencymarker gene expression reinforces
the footprint free reprogramming method (Fig. 2C). SOX2
expression remains high; representing the neural stemcells that
persist within the culture (9). The fact that VCPmutant iPSCs
can generate cortical neurons at a similar efficiency to control
lines hints at a normal capacity of VCPmutant cells for neuro-
genic differentiation and supports disease associated to aging
rather than developmental abnormalities. The glutamatergic
identity was confirmed by loading neurons with the cytosolic
calcium indicator Fura-2 and application of a physiological
concentration of glutamate (1M),which resulted in a transient
intracellular calcium signal (Fig. 2G). Furthermore, a mature
glutamatergic neuronal phenotype was validated via punctate
vGLUT1 staining and expression of the post-synaptic marker
PSD95 (Fig. 2H). Together, these results demonstrate an effec-
tive ability of the cells to differentiate into cortical neurons and
represent an appropriate model to study VCPmutations in the
cell type affected in FTD.
VCP and ANT expression is not affected in patient-derived
neurons
To further investigate the restricted ATP synthase substrate
supply through ANT, we employed patient-derived iPSCs and
cortical neurons bearing VCP mutations. First, we assessed
ANT1/2 gene expression on themRNA level in iPSCs and iPSC-
derived neuronswhere no significant changes could be found in
R155C or R191Q mutation-bearing cells (Fig. 3, A and B). Pro-
tein expression levels of VCP and ANT in the iPSC-derived
mutant neurons were also not changed when compared with
control neurons (Fig. 3, C and D); reinforcing the dominant-
negative theory that VCP mutations interfere with VCP hex-
amer function without affecting expression levels (10).
Mitochondrial swelling in iPSC-derived neurons bearing a VCP
mutation
Mitochondrial morphology was assessed in iPSC-derived
neurons by EM (representative images in Fig. 4A, i). We
observed that the number of swollen mitochondria in VCP
mutant R115C neurons and R191Q was significantly higher
(p 0.001) when compared with control neurons (Fig. 4A, ii).
This was confirmed in three independent neuronal inductions
and not seen in three parallel control cultures. Additionally,
swollen mitochondria displayed cristae that were disordered
and interdigitation was disrupted (Fig 4A, i, white arrows).
These observations in mitochondrial morphology further sup-
port that mitochondrial health is likely to be affected in VCP
mutant iPSC-derived neurons. It should be noted that abnor-
mal mitochondrial morphology has been witnessed in other
VCP mutant models, such as R155H homozygous and
heterozygous mice (3, 11).
Lower ATP synthase activity in VCPmutation bearing cells
Oxygen consumption measurements are an indirect assess-
ment of ATP synthase efficiency rather than ATP levels. To
measure mitochondrial ATP levels in real-time, a FRET-based
ATP probe was employed to allow assessment of ATP level
changes (12). Patient-derived iPSCs and neurons were trans-
fected with this probe where the fluorescent signal reflects
mitochondrial ATP levels (Fig. 4B). The transfected cells were
then permeabilized (40 M digitonin to permeabilize the
plasma membrane) in pseudo-intracellular solution and ATP
synthase activity was assessed in the presence of mitochondrial
substrates (5 mM malate and 5 mM glutamate) and ADP (500
nmol) (13). The applied ADP is translocated across the mito-
chondrial membranes via ANTwhere it is converted to ATP by
the ATP synthase. ATP binds to the probe, which allows fluo-
rescent live time recordings (Fig. 4C). All measurements were
carried out in 3 control cell lines and two patient cell lines
bearing either R155H or R191Q mutations (pool of two clones
each) and statistical analysis was carried out on the pool of all
control cell lines versusmutant cell lines.
iPSCs of affected patients had a significantly lower rate of
ATP synthesis when compared with control (Fig. 4D). The rate
of ATP increase in R155C (n  10) and R191Q (n  6) was
significantly slower (p  0.001) when compared with the
pooled unaffected iPSC controls (n 9; Fig. 4D). The rate was
also significantly lower in neurons bearing the R155Cmutation
(n 17; p 0.001; Fig. 4D) and R191Q mutation (n 12; p
0.05) when compared with control iPSC-derived neurons (n
13).
These results provide evidence that theATP synthase inVCP
mutant cells does not convert ADP to ATP as efficiently when
compared with control cells. However, this approach does not
distinguish between ATP synthase malfunction or a lower sub-
strate (ADP) supply as the underlying basis for the difference in
rate in ATP synthesis between control and VCPmutant cells.
ANT deregulation in VCPmutation bearing neurons
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ADP/ATP translocation is inhibited in VCPmutation bearing
cells
The translocase activity of ANT can be reversed through the
application of high concentrations of ATP to permeabilized
cells, which enables the import of ATP across the mitochon-
drial membranes. The translocated ATP is then bound by the
mitochondrial ATP probe and the kinetic fluorescentmeasure-
ments are a direct assessment of ATP translocation by ANT. It
should be noted that this process is independent of the ATP
synthase or ETC substrates and merely a measurement of ATP
uptake, hence ANT activity (Fig. 5A). This method allowed
investigation whether a lower substrate supply in the form of
ADP is the reason for uncoupling.
Application of ATP (500 nmol) to permeabilized cells re-
vealed a significantly slower ATP uptake into mitochondria of
R155C iPSCs (n 7; p 0.001) as well as R191Q iPSCs (n 14;
p 0.01) when compared with control cell lines (n 8; Fig. 5,
A and B). This observation was reproduced in iPSC neurons
where ATP uptake into the mitochondria was significantly
reduced in R155C neurons (p 0.001) and R191Q when com-
pared with control neurons (n 8; Fig. 5C).
As a proof of principle, permeabilized control iPSCs were
exposed to ANT inhibitors BKA or CATR for 30 min and the
rate of ATP uptake was recorded (Fig. 5, D and E). Mitochon-
dria pre-exposed to either ANT inhibitor displayed a signifi-
cantly reduced ATP uptake (CATR n  4; BKA n  5; p 
0.001), mirroring the uptake observed in untreated patient
iPSC (n 8), when compared with control (n 8). The rate of
ATP uptake in iPSC-derived control neurons exposed toCATR
(p 0.01) andBKA (p 0.05) was also significantly lowerwhen
compared with control neurons (n  3; Fig. 5E). These results
provide evidence that the mitochondrial uncoupling and lower
ATP levels inVCPmutation bearing cells are caused by a lack of
substrate (ADP) being translocated from the cytoplasm across
the mitochondrial membranes.
Discussion
We have previously shown that fibroblasts from patients
harboring mutations in the VCP gene display mitochondrial
uncoupling, seen by increased respiration, reduced oxidative
phosphorylation, and lower ATP levels (4). In the present study
we focused on the mechanism of this mitochondrial uncou-
Figure2.A, immunocytochemistry showing three control iPSCs and twopatient-derivedVCPmutant iPSCs lines (2 clones each). All stemcells showexpression
of pluripotencymarkers OCT4 and SSEA4 in stem cell conditions and have characteristic colonymorphology. By day 80 of differentiation,-III-tubulin positive
neurons are formed expressing markers of deep (TBR1), middle (CTIP2), and upper (SATB2) cortical neurons. Size bar  100 m. B, qPCR analysis of four
pluripotent stem cell markers in VCP patient-derived iPSCs and control fibroblasts, normalized to three housekeeping genes. C, qPCR analysis to represent
faithful silencing of pluripotency genes in neuronal cultures, relative to hESC controls. D, DNA sequencing of iPSC-derived neuron genomic DNA showing
mutated nucleotides corresponding to amino acid residues 155 and 191 (arrows). E,monolayer directed differentiation, showing the ability of newly derived
iPSC lines to enter the endoderm andmesoderm differentiation pathways. Size bar 50 m. F, automated counting of mature neuronal markers displays no
difference in the ability of control and VCP iPSCs to form deep (TBR1), middle (CTIP2), and upper (SATB2) layer cortical neurons. G, representative traces of
Fura-2-loaded iPSC-derived neurons showing a transient cytosolic calcium response to physiological concentrations of glutamate. Representative image
depicts iPSC-derived neurons loaded with Fura-2. H, iPSC-derived neurons express markers of glutamatergic neurons (vGLUT1) and functional synapses
(PSD95). Size bar 20 m.
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Figure 3. Quantification of ANT1/2 gene expression in iPSC (A) and iPSC-derived neurons (B) by qPCR. Number of repeats are indicated in the bar chart. C,
cropped Western blotting and D, densitometry analysis of VCP and ANT1/2 in iPSC-derived neurons. GAPDH was used as a loading control.
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pling. The UCP family and ANT both play an important role in
regulating the coupling of the mitochondrial respiratory chain
to oxidative phosphorylation. UCPs are mitochondrial carriers
functioning via dissipation of the proton gradient across the
inner membrane (14). To date, five human UCP homologues
have been identified in different tissues and all are located at the
mitochondria. UCP1 has a well characterized thermogenic role
in brown adipose tissue. UCP3 is mainly expressed in both
brown adipose tissue and muscle, whereas UCP2, UCP4, and
UCP5 are mainly expressed in the central nervous system and
therefore play key roles in neurons. Although only the role of
UCP1 has been well characterized, it is generally accepted that
all five UCPs uncouple oxidative phosphorylation from ATP
synthesis by dissipating the proton gradient across the inner
membrane (14).
Mitochondrial respiration analysis and Western blotting of
VCP KD cells established that uncoupling of respiration from
oxidative phosphorylation is not caused by UCPs or a proton
leak through the ATP synthase. However, ANT inhibition in
VCPKDdidnot lead to further uncoupling indicating thatANT
could already be inhibited. Classical uncoupling is understood
to be a reduction in coupling between the rate of electron trans-
port in the respiratory chain (ADP independent; State 4) and
ATP production (ADP-dependent; State 3) leading to a lower
RCR. However, a reduced substrate supply (ADP) through lim-
ited uptake via ANTwill lead to state 3 being inhibited resulting
also in a lowerRCR. Both scenarios decreaseATP levels andwill
ultimately lead to a lower bioenergetic status of the cell.
ANT1 is a mitochondrial protein that is thought to have an
intrinsic uncoupling property (15–17). Additionally, ANT1 has
been associated with themitochondrial permeability transition
poreandbelievedtobe involved inmitochondria-mediatedapo-
ptosis (18). This study provided evidence that reduced ANT
activity can lead tomitochondrial uncoupling as shownbyANT
inhibition in SCR cells. The observed mitochondrial deficiency
in VCP KD cells is in agreement with our previous work (4)
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Figure 4. A, i, transmission electronmicroscopy images of mitochondria within control andmutant iPSC-derived neurons at day 80 of differentiation. Mutant
neurons consistently display a small proportion of swollen, electron dense mitochondria. Arrows show damaged cristae. Scale bar represent 1 m. ii, quanti-
fication of swollen mitochondria. n  3 control, n  3 R155C and n  1 R191Q. B, representative image of a neuron transfected with mitAT1.03 probe. C,
representative traces of mitochondrial ATP after ADP application. Oligomycin was applied as a negative control. Scale bar represent 10 m. D, quantification
of the rate of ATP increase in control and VCP mutation bearing iPS cells. E, quantification of the rate of ATP increase in control and VCP iPS-derived neurons.
*, p 0.05; *, p 0.05; ***, p 0.001.
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where a lower NADH redox index and faster basal V2 respira-
tion in VCP KD cells was reported. These features, together
with a lower RCR, have been implicated in a number of neuro-
degenerative models. For example, Plun-Favreau et al. (6)
showed similar phenotypes in an HTRA2 knock-out mouse
model wheremutations in theHTRA2 gene have been linked to
Parkinson’s disease. Additionally, studies have shown how the
most common genetic cause of Parkinson’s disease, G2019S
mutations in the leucine-rich repeat kinase 2 gene (LRRK2),
displayed uncoupling and low RCR implicating UCP2 and -4
proteins (19). Other transgenic mice for Huntington’s disease
reflectedmetabolic and thermoregulatory defects associated to
uncoupling and reduced RCRs (20).
We extended our study by employing VCP patient-derived
iPSCs and iPSC-derived neurons, which allowed us to investi-
gate the dynamics of ADP and ATP translocation at the mito-
chondria in a human neuronal model. Investigations utilizing
this highly energy-demanding cell type enabled us to validate
previously observed mitochondrial abnormalities in the cell
type affected by FTD.
Electron microscopy of mitochondria in iPSC-derived neu-
rons displayed a significantly higher subset of swollen mito-
chondria that exhibit disordered inner mitochondrial mem-
branes in VCP-deficient cells compared with those from
control derived neurons. Damaged mitochondria were de-
scribed as a common feature in VCP-associated disease models
and in patient cell samples but there have been no reports
showing this feature in neurons (5, 11, 21). For example, John-
son et al. (21) in 2015 showed damagedmitochondria inmuscle
cells fromDrosophila andNalbandian et al. (11) in 2012 showed
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Figure 5. A, representative traces of mitochondrial ATP uptake. B, quantification of the rate of ATP uptake in control and VCP mutation bearing iPS cells. C,
quantification of the rate of ATP uptake in control and VCP iPS-derived neurons. D, quantification of the rate of ATP uptake in control iPSCs or pre-exposed to
ANT inhibitors (BKA/ATRAC) as well as mutation bearing iPSCs. E, quantification of the rate of ATP uptake in control neurons, neurons pre-exposed to ANT
inhibitors (BKA/ATRAC), and mutations bearing neurons. *, p 0.05; **, p 0.01; ***, p 0.001.
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mitochondrial megaconia and disrupted cristae in myoblasts
from a VCP mouse model. The same group more recently
showed damaged mitochondrial dynamics and function in
fibroblasts and myoblasts from VCP patients (5). Here for the
first time, we are showing EM images of damagedmitochondria
in human neurons withVCPmutations. Additionally, the swol-
len mitochondria observed in the VCP mutant neurons could
be an indicator of uncoupling, a feature originally described by
Weinbach et al. (22) in 1963 and subsequently confirmed in a
number of reports (23, 24).
The results suggest a decreased transport of ADP/ATP by
ANT, which explains the mechanism behind the reduced ATP
levels in the cells as previously shown in multiple other disease
models (5, 25, 26). Inhibition of ADP/ATP transport could be
observed in all cell types employed by this study. However, neu-
rons requiremore energy than any other cell type (such as iPSC)
and rely predominantly on oxidative phosphorylation for ATP
production (with a very small impact of glycolysis). This makes
neurons more vulnerable to mitochondrial uncoupling and
inhibition of ATP transport (27).
Our data provide evidence that mutations in VCP lead to
mitochondrial uncoupling due to a reduced ADP/ATP translo-
cation by ANT. Here we provide unique analysis of the bioen-
ergetics ofVCPmutant humanneuronswith patient genotypes,
allowing rational and relevant bioenergetic analysis in the cell
type affected by neurodegeneration. The underlying deficiency
in mitochondrial bioenergetics may help to explain disease in
the context of VCP mutation and provide a focus for further
studies into the brain metabolism in healthy aging and disease.
Experimental procedures
Cell culture
Human neuroblastoma (SH-SY5Y) cells were purchased
from the European Collection of Cell Cultures (Health Protec-
tion Agency, Salisbury, UK) and maintained as previously
described (28). Unless otherwise stated, SH-SY5Y cells were
seeded at a density of 4  104 cells/cm2 and maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% (v/v) fetal bovine serum (FBS), 2mM L-glutamine, and
1% (v/v) penicillin/streptomycin at 37 °C and 5% CO2. The
scramble and VCP KD SH-SY5Y cells were generated by lenti-
viral infection with either a pool of 5 shRNA vectors or individ-
uals shRNA (Thermo Fisher) as described previously by Bar-
tolome et al. (4). Subsequent clonal selection was carried out
using puromycin (1 g/ml). Two different independent clones
and a pool with 90% approximate reduction in gene expression
were used in all experiments. 1 clone expressing nontargeting
RNA vector was used as control (stable SCR).
Cell differentiation
Fibroblast and iPSC cultures were performed as described
previously (29, 30) and all reagents were obtained from Life
Technologies, unless otherwise stated. Clinical data about the
patients was described previously (4). Fibroblasts were cultured
inDMEMwith 10% fetal bovine serumandpassagedwith 0.05%
trypsin. Reprogramming was performed as per the method
detailed by Okita et al. (7) using episomal reprogramming plas-
mids (given as a gift from Shinya Yamanaka; Addgene plasmids
#27077, #27078, and #27080) and the P2 nucleofection kit
(Amaxa). One week after nucleofection, cells were passaged
onto mouse embryonic feeders (AMS Bio) and media was
changed to KO-DMEM, 20% knock-out serum replacement, 2
mM L-glutamine, non-essential amino acids, 50 M -mercap-
toethanol, and 10 ng of FGF2 (Peprotech).
Newly formed iPSC colonies were manually picked and,
together with control iPSCs and hESCs, were maintained in
Essential 8 medium on Geltrex-coated plates. Karyotype anal-
ysis was performed by Cell Guidance Systems, Cambridge, UK.
Differentiation to cortical neurons was performed as detailed
(8, 34). 10 days of dual SMAD inhibition using 1 M dorsomor-
phin and 10 M SB431542 was followed by 70–90 additional
days of differentiation in N2B27 media containing retinoids on
laminin-coated dishes and coverslips. The hESC line SHEF6
was obtained from the United Kingdom Stem Cell Bank, con-
trol iPS line 1 was obtained from the lab of Dr. Tilo Kunath, and
control iPS line 2 from Coriell repository.
For mesoderm and endoderm fate specification a defined
monolayer protocol was followed, which allowed up-regulation
of mesoderm- and endoderm-specific fate determinant gene
networks, as published by others (31, 32). In brief, endoderm
differentiation was achieved via a 3-day treatment consisting of
0.1 g/ml of activin (days 1–3), 80 ng/ml of FGF2 (days 1–3), 10
ng/ml of BMP4 (days 1–2), and 3 M Chir (day 1). Mesoderm
differentiation was directed via a 2-day treatment with 0.1
g/ml of Activin, 20 ng/ml of FGF2, 10 ng/ml of BMP4, and 5
M Chir.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde for 15 min and
washed three times in PBS containing 0.3% Triton X-100
(PBST), before blocking in 3%BSA in PBST for 20min. Primary
antibodies (Table 1) were incubated overnight at 4 °C in block-
ing solution, followed by threewashes in PBST. Secondary anti-
bodies were then added for 1 h at room temperature in the dark
(Alexa Fluor, Invitrogen), DAPIwas added for onewash at 1M
and a final twowasheswas performed in PBSTbeforemounting
the coverslips for imaging on a Zeiss LSMmicroscope or a Zen
confocal microscope. Cell counts were performed on 5 images
per condition from three independent experiments, using the
Table 1
Antibodies used for immunocytochemistry andWestern blotting
Antibody name Source Dilution Species
OCT4 Santa Cruz 1:500 gt
SSEA4 BioLegend 1:200 m
MAP2 Abcam 1:10,000 ch
PSD95 Abcam 1:1000 m
vGLUT1 Synaptic systems 1:1000 rb
TUJ1 Covance 1:1000 m/rb
TBR1 Abcam 1:500 rb
SATB2 Abcam 1:100 m
CTIP Abcam 1:500 rat
VCP Cell Signalling 1:1000 m
ANT1/2/3 Santa Cruz 1:200 gt
UCP2 (C-20) Santa Cruz 1:200 gt
GAPDH Ambion 1:5000 m
-actin Sigma 1:5000 rb
hGATA-4 Santa Cruz 1:100 m
hSox17 R&D 1:200 gt
hCDX1 Abcam 1:200 r
OXPHOS complexes Abcam 1:250 m
ANT deregulation in VCPmutation bearing neurons
8914 J. Biol. Chem. (2017) 292(21) 8907–8917
 at RO
Y
A
L V
ET CO
LL./LIBRA
RIA
N
 on July 24, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ITCN nuclear counting software plug-in for ImageJ with con-
sistent settings between all conditions.
Western blotting analysis
Cells were lysed for 1 h at 4 °C in lysis buffer containing 10
mM Tris, pH 8, 140 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 1%
Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS plus prote-
ase and phosphatase inhibitors (RocheApplied Science), before
centrifugation at 10,000 rpm for 15 min at 4 °C. Proteins were
separated on NuPage 10% SDS-polyacrylamide gels (Novex)
and transferred onto nitrocellulose membranes. Membranes
were blocked in PBS containing 0.1% Tween and 3%milk solu-
tion. Primary antibodies were incubated in blocking solution
overnight at 4 °C (Table 1). Subsequent washes were performed
in PBS-Tween and secondary antibodies (800 nmRockland and
680 nmMolecular Probes) were incubated for 1 h at room tem-
perature. Final washes were in PBS and membranes were
scanned on an Odyssey imaging system (Li-Cor). All gels have
been run under the same experimental conditions.
qPCR analysis
RNA was isolated from cells using TRIzol reagent and the
manufacturer’s instructions (Thermo Fisher). Reverse tran-
scription was performed using SuperScript III Reverse Tran-
scriptase and randomhexamer primers (Thermo Fisher). qPCR
was performed using Power SYBR Green master mix (Thermo
Fisher) and the Agilent Mx300P qPCR system and software
with annealing of primers at 60 °C (Table 2). All results are
relative to the expression of three housekeeping genes, GAPDH,
CYCLOPHILIN, and -ACTIN.
Sanger sequencing
Genomic DNA was extracted from VCP cells using the
QuickExtract DNA extraction solution (Epicenter) as per the
manufacturer’s instructions. The regions of the VCPmutations
were PCR amplified with VCP exon 5 (forward, TTAAGACA-
GGTGGGGTGGAG; reverse, CCCATCTCAGTCTCCCA-
AAG) primers using POLYMERASEHERE (itmay be: FastStart
PCRMaster (Roche Applied Science)) in PCR containing 10 l
of FastStart of PCRMaster, 1 l of each primer, 1 l of DMSO,
10 l of H2O, and 1 l of extracted gDNA. PCR was performed
using a 65td55 standard cycling program. PCR products were
subsequently purified by incubation with Exonuclease I/
FastAPTM Thermosensitive Alkaline Phosphatase (Thermo
Scientific) mixture as per the manufacturer’s instructions. 5 l
of purified products were used in sequencing reactions with 0.5
l of Big Dye (BigDye Terminator V.3.1 Cycle Sequencing Kit,
Applied Biosystems), 2l of sequencing buffer (BigDye Termi-
nator V.3.1 Cycle Sequencing Kit, Applied Biosystems), 1 l of
primer, and 2.5 l of H2O. For the removal of BigDye Termi-
nator, sequencing reactions were filtered through Sephadex
(Sigma) containing filter plates (Corning). Sequencing was per-
formed using an Applied Biosystems 3730XI Sequencer and
analysis of results was carried out using the Sequencher soft-
ware (Gene Codes Corporation).
Transmission electronmicroscopy
Neurons were fixed in 3% gluteraldehyde (EM grade, Agar
Scientific), 0.1 M sodium cacodylate, and 5 mM calcium chlo-
ride. Neurons were then post-fixed in osmium tetroxide,
stained with uranyl acetate and Reynold’s lead citrate, and
dehydrated with stepwise washes with increasing concentra-
tions of ethanol. Cells were then mounted in epoxy resin using
propylene oxide to aid infiltration, whichwas hardened at 60 °C
for 2 days. Ultrathin sections were taken using a diamond knife
(Leica Reichert Ultracut), sections were mounted on copper
mesh grids, stained with uranyl acetate, and images were taken
using the Philips CM12 transmission electron microscope
using the Olympus Soft Imaging System iTEM and Mega-
ViewIII camera. Mitochondria were analyzed in triplicate from
two control lines and one line from each patient. At least 15
fields of view were analyzed per line for every replicate.
Oxygen consumptionmeasurements
SH-SY5Y cells were permeabilized with 40 M digitonin and
subsequent re-suspension in a hypotonic medium containing
135 mM KCl, 10 mM NaCl, 20 mM HEPES, 0.5 mM KH2PO4, 1
mM MgCl2, 5 mM EGTA, and 1.86 mM CaCl2, pH 7.1. Oxygen
consumption wasmeasured in the Clark-type oxygen electrode
(Hansatech) thermostatically maintained at 25 °C. Glutamate
(5 mM), malate (5 mM), and inhibitors were indicated were
added to the chamber before the measurement took place. To
assessV3, 50 nmol ofADPwas added and all datawere obtained
using the Oxygraph Plus system with chart recording software.
Fura-2 imaging
Calciummeasurements using fura-2were generated using an
epifluorescence inverted microscope equipped with a20 flu-
orite objective (33). Changes in cytosolic calcium levels were
monitored in single cells using excitation light provided by a
Xenon arc lamp, the beam passing monochromator at 340 and
380 nm (Cairn Research, UK). The emitted fluorescence light
was reflected through a 515-nm long pass filter to a cooledCCD
camera (Retiga, QImaging, Canada) and digitized to 12-bit res-
Table 2
Primers used for qPCR
Gene Forward Primer Reverse Primer Product
GAPDH atgacatcaagaaggtggtg cataccaggaaatgagcttg 177 bp
CYCLOPHILIN ggcaaatgctggaccaaacac ttcctggacccaaaacgctc 147 bp
-ACTIN tcaccaccacggccgagcg tctccttctgcatcctgtcg 351 bp
OCT4 ttctggcgccggttacagaacca gacaacaatgaaaatcttcaggaga 218 bp
SOX2 catggcaatcaaaatgtcca tttcacgtttgcaactgtcc 119 bp
NANOG gcttgccttgctttgaagca ttcttgactgggaccttgtc 256 bp
ANT1 aagatcttcaagtctgatgg ataatatcggcccctttc 263 bp
ANT2 gcttgtcttgtatgatgaa aatagttgccactgagaa 145 bp
DNMT3b tttagggagaacgggaat agcaccagtaagaagagt 88 bp
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olution. All imaging data were collected and analyzed using
software from Andor (Belfast, UK).
Kinetic ATPmeasurements
To determine the ATP levels, patient-derived iPSC and
neurons were transfected with a mitochondrial ATP probe
(mitAT1.03), which was generated by Imamura et al. (12) using
Effectine (Qiagen) according to the manufacturer’s instruc-
tions. Confocal images were obtained using a Zeiss 710 VIS
CLSM microscope equipped with a META detection system
and a40 oil immersion objective. The FRETwas quantified by
the 527:475 nm ratio with an excitation of 405 nm and a filter
from 515 to 580 nm. ATP kinetics were assessed in permeabi-
lized iPSC and iPSC-derived neurons. To permeabilize the
transfected cells, a buffer (0.137 M NaCl, 5 mM KCl, 0.7 mM,
NaH2PO4, 25 mM, Tris-HCl, pH 7.1) containing a low concen-
tration of digitonin (20 M) was added to the cells. Upon per-
meabilization, the buffer containing digitonin was replaced by
fresh buffer containing mitochondrial substrates (5 mM gluta-
mate and 5 mMmalate). Cells were allowed to rest for at least 5
min beforemeasurements took place. Basalmitochondrial ATP
levels were recorded for 1 min before 500 nmol of ADP/ATP
was added to the imaging chamber (500 l final volume). Oli-
gomycin (2g/ml) was added as a negative control at the end of
the ADP experiments.
Statistical analysis
Statistical analysis and exponential curve fitting were per-
formed using Origin 9 (Microcal Software Inc., Northampton,
MA) software. Experimental data are shown as column scat-
ter  S.D. n represents experiments undertaken. Statistical
analysis between samples was performed using a one-way anal-
ysis of variance with Bonferroni correction. Differences were
considered to be significantly different if p 0.05 (*).
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